BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 9651945)

  • 1. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
    Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
    Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo aneuploidization during the expansion of renal adenocarcinoma.
    Di Capua Sacoto C; Budia Alba A; Alapont Alacreu JM; Ruiz Cerda JL; Jimenez Cruz JF
    Urol Int; 2011; 86(4):466-9. PubMed ID: 21546757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal cell carcinoma: DNA cytometry and its clinical significance. An 8 year survival study].
    al-Abadi H; Nagel R
    Helv Chir Acta; 1991 Sep; 58(3):331-4. PubMed ID: 1769855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
    Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
    Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant interferon alpha therapy in renal cell carcinoma (RCC): prognostic value of DNA cytophotometry.
    Basting R; Corvin S; Händel D; Hinke A; Schmidt D
    Anticancer Res; 1999; 19(2C):1493-5. PubMed ID: 10365130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis.
    Yu DS; Hsu CM; Lee WH; Chang SY; Ma CP
    J Surg Res; 1993 Nov; 55(5):480-5. PubMed ID: 8231166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
    Eskelinen M; Lipponen P; Nordling S
    Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of flow cytometric, static cytometry and tumor cytogenetic investigation results human renal cell carcinomas].
    Krech RH; Baretton G; Fonatsch C; Diebold J; Früchtnicht W; Löhrs U
    Verh Dtsch Ges Pathol; 1990; 74():228-32. PubMed ID: 1708590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of DNA ploidy in small renal cell carcinoma.
    Shalev M; Gdor Y; Leventis A; Radnay J; Shapiro H; Bernheim J; Nissenkorn I
    Pathol Res Pract; 2001; 197(1):7-12. PubMed ID: 11209819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vivo DNA aneuploidization during expansion of conventional renal cell carcinoma.
    Li G; Cottier M; Sabido O; Gentil-Perret A; Lambert C; Passebosc-Faure K; Genin C; Tostain J
    In Vivo; 2002; 16(5):341-4. PubMed ID: 12494875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic significance of DNA ploidy pattern on bile duct cancer].
    Sato Y; Tanaka J; Seki H; Kato Y; Umezawa A; Koyama K
    Nihon Geka Gakkai Zasshi; 1994 Apr; 95(4):259-62. PubMed ID: 8196593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary renal cell carcinoma: clinical implication of DNA content analysis.
    el-Naggar AK; Ro JY; Ensign LG
    Hum Pathol; 1993 Mar; 24(3):316-21. PubMed ID: 8454276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?
    Skolarikos A; Alivizatos G; Bamias A; Mitropoulos D; Ferakis N; Deliveliotis C; Dimopoulos MA
    Int J Urol; 2005 Jun; 12(6):563-9. PubMed ID: 15985079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the prognostic value of DNA ploidy and proliferation index (Ki-67) in renal cell carcinoma with venous thrombus].
    Rey D; Pfister C; Gobet F; Martinez S; Staerman F; Grise P
    Prog Urol; 2003 Dec; 13(6):1300-6. PubMed ID: 15000303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
    Currin SM; Lee SE; Walther PJ
    J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow-cytometric analysis of the DNA content in paraffin-embedded tissue and in fresh tumour samples obtained from renal cell carcinoma: comparison of DNA ploidy using ethidium bromide and mithramycin.
    Fischer C; Knaust KO; Schauer A; Ringert RH
    Anticancer Res; 1996; 16(5A):2575-80. PubMed ID: 8917354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.